The ACE I/D Polymorphism and Human Physical Performance
暂无分享,去创建一个
[1] R. Mayfield,et al. Tissue kallikrein and bradykinin do not have direct insulin-like actions on skeletal muscle glucose utilization. , 1987, Biological Chemistry Hoppe-Seyler.
[2] G. Ferretti,et al. Physiological profile of world-class high-altitude climbers. , 1986, Journal of applied physiology.
[3] D R Bassett,et al. Limiting factors for maximum oxygen uptake and determinants of endurance performance. , 2000, Medicine and science in sports and exercise.
[4] Jimmy D Bell,et al. Human gene for physical performance , 1998, Nature.
[5] N. Iwai,et al. Expression of angiotensin converting enzyme and chymase in human atria , 1997, Journal of hypertension.
[6] F. Cobb,et al. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. , 1990, Circulation.
[7] C. Mamotte,et al. Elite athletes and the gene for angiotensin-converting enzyme. , 1999, Journal of applied physiology.
[8] R. Minshall,et al. Bradykinin B2 Receptors on Skeletal Muscle are Coupled to Inositol 1,4,5-Trisphosphate Formation , 1996, Diabetes.
[9] Jimmy D Bell,et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training , 1999, The Lancet.
[10] G S Krahenbuhl,et al. Running economy and distance running performance of highly trained athletes. , 1980, Medicine and science in sports and exercise.
[11] G. Radda,et al. Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis. , 1996, Heart.
[12] W. Linz,et al. Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies , 1996, Diabetes.
[13] G. Pontone,et al. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure. , 1999, The American journal of cardiology.
[14] J. Karjalainen,et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. , 1999, Journal of the American College of Cardiology.
[15] R. Ferrell,et al. VO2 max is associated with ACE genotype in postmenopausal women. , 1998, Journal of applied physiology.
[16] R. Schifman,et al. Insulin-like activity of bradykinin on amino acid balances across the human forearm. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[17] C. Bouchard,et al. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. , 2000, Journal of applied physiology.
[18] Vicotor J Dzau,et al. Circulating versus local renin‐angiotensin system in cardiovascular homeostasis , 1988, Circulation.
[19] J H Wilmore,et al. Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. , 2000, Journal of applied physiology.
[20] M. Brink,et al. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. , 1996, The Journal of clinical investigation.
[21] H. Mehnert,et al. Dose-dependent effect of bradykinin on muscular blood flow and glucose uptake in man. , 1983, Hoppe-Seyler´s Zeitschrift für physiologische Chemie.
[22] K. Williams,et al. Three-dimensional structure of the ion-coupled transport protein NhaA , 2000, Nature.
[23] H. E. Montgomery,et al. Physiology: The ACE gene and muscle performance , 2000, Nature.
[24] J. Holloszy,et al. Bradykinin does not mediate activation of glucose transport by muscle contraction. , 1986, Journal of applied physiology.
[25] H. Schunkert,et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. , 1995, Circulation.
[26] P. Cerretelli,et al. II. Morphological Adaptations of Human Skeletal Muscle to Chronic Hypoxia* , 1990, International journal of sports medicine.
[27] R. Minshall,et al. Kininase II-Type Enzymes: Their Putative Role in Muscle Energy Metabolism , 1996, Diabetes.
[28] Bing Yu,et al. Elite endurance athletes and the ACE I allele – the role of genes in athletic performance , 1998, Human Genetics.
[29] W. Linz,et al. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. , 1986, Journal of cardiovascular pharmacology.
[30] L. Zisman. Inhibiting tissue angiotensin-converting enzyme: a pound of flesh without the blood? , 1998, Circulation.
[31] A. Morris,et al. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. , 1999, Hypertension.
[32] K. Swedberg,et al. Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure. , 1998, Journal of cardiac failure.
[33] H. Predel,et al. ACE inhibition and physical exercise: studies on physical work capacity, energy metabolism, and maximum oxygen uptake in well-trained, healthy subjects. , 1994, Journal of cardiovascular pharmacology.
[34] E. Coyle,et al. Cycling efficiency is related to the percentage of type I muscle fibers. , 1992, Medicine and science in sports and exercise.
[35] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[36] N. Brown,et al. ACE insertion/deletion genotype affects bradykinin metabolism. , 1998, Journal of cardiovascular pharmacology.
[37] C. Bouchard,et al. Individual differences in the response to regular exercise. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[38] J H Wilmore,et al. Familial resemblance for VO2max in the sedentary state: the HERITAGE family study. , 1998, Medicine and science in sports and exercise.
[39] D. Hoefnagel,et al. Partial lipodystrophy and familial C3 deficiency. , 1980, Human heredity.
[40] P. Game,et al. The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. , 1994, Blood pressure.
[41] H Hemingway,et al. Human angiotensin I-converting enzyme gene and endurance performance. , 1999, Journal of applied physiology.
[42] T J Walters,et al. Determinants of endurance in well-trained cyclists. , 1988, Journal of applied physiology.
[43] P. Shetty,et al. Net mechanical efficiency during stepping in chronically energy-deficient human subjects. , 1992, Annals of human biology.
[44] Increased muscular efficiency during lactation in Colombian women , 1998, European Journal of Clinical Nutrition.
[45] G. Brooks,et al. Muscular efficiency during steady-rate exercise: effects of speed and work rate. , 1975, Journal of applied physiology.
[46] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[47] P. Agostoni,et al. Angiotensin‐converting enzyme inhibition facilitates alveolar‐capillary gas transfer and improves ventilation‐perfusion coupling in patients with left ventricular dysfunction , 1999, Clinical pharmacology and therapeutics.
[48] C. Bouchard,et al. Aerobic performance in brothers, dizygotic and monozygotic twins. , 1986, Medicine and science in sports and exercise.
[49] J. Ménard,et al. Vascular angiotensin-converting enzyme expression regulates local angiotensin II. , 1997, Hypertension.
[50] A. Minetti,et al. IV. Oxygen Transport System Before and After Exposure to Chronic Hypoxia , 1990, International journal of sports medicine.
[51] W. Linz,et al. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. , 1990, European journal of pharmacology.